Similarly, the TOPK inhibitor OTS514 suppresses cancer cell proliferation by downregulating E2F target genes and inhibiting FOXM1 and MELK activities, thereby inducing cell cycle arrest and apoptosis through the p53 signaling pathway. The gene discussed is MELK; the disease is cancer.